A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

Save

Report Abuse

Description

Participants will a diagnosis of gastroesophageal junction (GEJ) adenocarcinoma and will have either a minimally invasive proximal gastrectomy (MIPG) or a minimally invasive total gastrectomy (MITG) as part of their routine care. Participants with complete a questionnaire 1 month before the surgical procedure and then 1, 3, 6 and 12 months after the surgical procedure.

Study Overview

Start Date
January 8, 2024
Completion Date
January 8, 2036
Enrollment
10
Date Posted
February 6, 2024
Accepts Healthy Volunteers?
No
Gender
All

Locations

Full Address
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey 07920, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey 07748, United States

Memorial Sloan Kettering Bergen (All protocol activities)
Montvale, New Jersey 07645, United States

Memorial Sloan Kettering Commack (All Protocol Activities)
Commack, New York 11725, United States

Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York 10604, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activites)
Rockville Centre, New York 11553, United States

MD Anderson Cancer Center (Data Analysis Only)
Houston, Texas 77030, United States

Eligibility

Study Population
The initial contact with the potential participants will be conducted either by the treatment team, investigator or the research staff working in consultation with the treatment team. Participants will be screened in gastric and mixed tumor surgery clinics on the 5th floor of the MSKCC 53rd Street outpatient clinic building. The investigator/research staff will review portions of the medical record to determine if they are eligible. Participants who are eligible will be approached by study personnel in clinic. The study will be explained to participants by the study personnel and interested participants will be given the consent form to review.
Minimum Age (years)
18
Eligibility Criteria
Inclusion Criteria:

Able to speak and read English, Spanish, Japanese or Korean
Patients with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
Age ≥ 18

Exclusion Criteria:

Patients with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
Patients with known narcotic dependence, with average daily dose > 5 mg oral morphine equivalent
Subjects deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
Patients who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)

Study Contact Info

Study Contact Name
Vivian Strong, MD; Daniel Coit, MD
Study Contact Phone

Contact Listings Owner Form

A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
NCTid (if applicable)
NCT06243757